Safran SA
OTC:SAFRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Safran SA
OTC:SAFRY
|
FR |
|
B
|
BioCryst Pharmaceuticals Inc
F:BO1
|
US |
|
TopBuild Corp
NYSE:BLD
|
US |
|
S
|
SoftBank Group Corp
XHAM:SFT
|
JP |
|
London Stock Exchange Group PLC
F:LS4D
|
UK |
|
Erste Group Bank AG
F:EBO
|
AT |
|
Dingdong (Cayman) Ltd
NYSE:DDL
|
CN |
|
Ecovyst Inc
F:PQGA
|
US |
|
E
|
Eagle Plains Resources Ltd
OTC:EGPLF
|
CA |
|
BEC World PCL
OTC:BECVY
|
TH |
|
Rexel SA
OTC:RXLSF
|
FR |
|
G
|
General Electric Co
XHAN:GCP
|
US |
Intrinsic Value
The intrinsic value for
Safran SA (SAFRY) under the Base Case is hidden
USD.
Compared with the current market price of 101.31 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
SAFRY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether SAFRY usually does or if today's premium is unusual.
See where today’s valuation sits in SAFRY’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Safran SA.
The intrinsic value for
Safran SA (SAFRY) under the Base Case is hidden USD.
Compared with the current market price of 101.31 USD, the stock appears hidden.